Intrathecal injection of the neurosteroid, DHEAS, produces mechanical allodynia in mice: involvement of spinal sigma‐1 and GABAAreceptors
Open Access
- 3 June 2009
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 157 (4) , 666-673
Abstract
Background and purpose: The neurosteroid, dehydroepiandrosterone sulphate (DHEAS) and its non‐sulphated form, DHEA, are considered as crucial endogenous modulators of a number of important physiological events. Evidence suggests that DHEAS and DHEA modulate central nervous system‐related functions by activating sigma‐1 receptors and/or allosterically inhibiting γ‐aminobutyric acic receptor type A (GABAA) receptors. As both the sigma‐1 receptor and the GABAAreceptor play important roles in spinal pain transmission, the present study was designed to examine whether intrathecally injected DHEAS or DHEA affect nociceptive signalling at the spinal cord level.Experimental approach: We first determined whether intrathecal (i.t.) DHEA or DHEAS injection was able to affect nociceptive thresholds to peripheral mechanical stimulation and subsequently examined whether this effect was mediated by sigma‐1 or the GABAAreceptors.Key results: The i.t. DHEAS injection dose‐dependently decreased the nociceptive threshold to mechanical stimulation, thus producing mechanical allodynia. Moreover, this DHEAS‐induced mechanical allodynia was significantly reduced by administration of the sigma‐1 receptor antagonist, BD‐1047 or the GABAAreceptor agonist, muscimol. Conversely, i.t. DHEA had no effect on mechanical sensitivity. However, when i.t. DHEA was combined with the GABAAreceptor antagonist bicuculline, DHEA dose‐dependently produced mechanical allodynia similar to that of DHEAS. This effect was blocked by BD‐1047 and by muscimol.Conclusions and implications: These findings indicate that i.t. injection of DHEAS produces mechanical allodynia and that the development of this mechanical allodynia is mediated by sigma‐1 and GABAAreceptors. The findings of this study raise several interesting questions for further investigations into the mechanisms underlying neurosteroid modulation of spinal pain transmission.British Journal of Pharmacology(2009)157,666–673; doi:10.1111/j.1476‐5381.2009.00197.x; published online 30 April 2009Keywords
This publication has 47 references indexed in Scilit:
- Intrathecal Injection of the ς1Receptor Antagonist BD1047 Blocks Both Mechanical Allodynia and Increases in Spinal NR1 Expression during the Induction Phase of Rodent Neuropathic PainAnesthesiology, 2008
- Intrathecal administration of sigma‐1 receptor agonists facilitates nociception: Involvement of a protein kinase C–dependent pathwayJournal of Neuroscience Research, 2008
- Activation of the spinal sigma‐1 receptor enhances NMDA‐induced pain via PKC‐ and PKA‐dependent phosphorylation of the NR1 subunit in miceBritish Journal of Pharmacology, 2008
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptorsExperimental Neurology, 2008
- Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cordThe FASEB Journal, 2007
- Intrathecal treatment withσ1receptor antagonists reduces formalin‐induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in miceBritish Journal of Pharmacology, 2006
- The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depressionEuropean Neuropsychopharmacology, 2005
- Modulation of GABA-Gated Chloride Ion Influx in the Brain by Dehydroepiandrosterone and Its MetabolitesBiochemical and Biophysical Research Communications, 1998
- Efficient Analysis of Experimental ObservationsAnnual Review of Pharmacology and Toxicology, 1980